Background
Bile acids are normal constituents of the gastro-intestinal tract where they act as trophic factors for the gut epithelium and as detergents for the absorption of cholesterol and fat-soluble vitamins [
1,
2]. Typical Western diets, rich in fat, are associated with increased incidence of gastro-intestinal cancer [
3]. Dietary fat influences bile acid secretion as well as the composition of gut bacteria, which in turn determines the production levels of secondary bile acids [
4‐
7].
While bile acids such as DCA cannot induce tumors, they are generally believed to be tumor promoters. The exact mechanism of their tumor promoting activity is uncertain but it is thought to involve alterations in cellular signaling cascades including activation of protein kinase C and gene expression systems [
8]. Bile acids are known mediators of cellular stress [
9] and have been proposed to induce apoptosis resulting in compensatory hyperproliferation, allowing for selection of apoptosis-resistant cells [
10,
11]. Bile acids are also known to induce survival mechanisms in parallel with apoptotic pathways in hepatocytes and colonic cells [
12,
13].
Over the past two decades there has been a significant increase in the incidence of Barrett's esophagus [
14], a premalignant lesion leading to esophageal adenocarcinoma. This condition characterized by small intestinal metaplasia of esophageal epithelium is strongly associated with gastroesophageal reflux disease (GERD). Reflux of duodenal contents, of which bile acids are a major constituent, has been consistently associated with increased severity of both esophagitis and Barrett's esophagus [
15,
16]. Barrett's metaplasia has been reported in patients with bile reflux without any pathological acid reflux, as well as in patients on acid suppression therapy, highlighting the importance of refluxate components other than acid in esophageal cancer progression [
17,
18]. The concentration of bile acids, in particular unconjugated bile acids, in the refluxate of patients with GERD shows a strong direct correlation with the degree of esophageal mucosal damage [
16,
18]. Compelling evidence for the involvement of bile acids in Barrett's esophagus has also emerged from animal studies, where reflux leads to esophageal inflammation, increased mucosal thickening [
19] and development of malignancy. These epidemiological and clinical studies clearly establish a link between bile acids in the refluxate and esophageal malignancies. However, the precise molecular mechanisms remain unexplored.
The transcription factor AP-1 is activated by a variety of stimuli and can have both anti-apoptotic and pro-apoptotic functions depending on the cellular context [
20]. A correlation between AP-1 and tumorigenesis has been suggested. AP-1 shows increased activity in transformed cell lines [
21] and its transactivation is required for tumor promotion
in vivo [
22]. The AP-1 complex is composed of dimers between the Fos (c-Fos, FosB, Fra-1 and Fra-2) and the Jun (c-Jun, JunB, and JunD) family members. Fos and Jun proteins can form heterodimers while only the members of the Jun family are capable of homodimerisation. Fos/Jun heterodimers are more stable than Jun homodimers [
23]. AP-1 dimer composition is critical in determining its functional activity and consequently in the induction of specific target genes [
20,
24,
25]. Upstream signalling pathways, mainly mitogen-activated protein kinases(MAPKs), regulate the transcriptional activity and half-life of proteins of the Fos and Jun families giving rise to AP-1 dimers of different transcriptional specificity. Alterations in MAPK signaling have been correlated with malignant progression in humans [
26,
27]. The MAPK family includes three subfamilies: Erk1/2, p38 and JNK, all of which have been shown to be activated in response to DCA in several cell types including colonic cells, hepatocytes and cholangiocarcinoma cells [
11,
28].
Cyclooxygenase-2 (COX-2), the rate-limiting enzyme in aracidonic acid metabolism, has been correlated with resistance to apoptosis, inflammation and cancer in several cell types [
13,
19,
29]. COX-2 is upregulated in Barrett's esophagus, esophageal cancer and in animal models of reflux [
19,
30,
31]. COX2 expression can be regulated by MAPKs post-transcriptionally through mRNA stabilization or via activation of AP-1 complexes [
32]. Recently, Song
et al. [
33] have demonstrated that unconjugated bile acids such as deoxycholate induced CREB- and AP-1-dependent COX-2 expression in esophageal adenocarcinoma cells and
in vivo rat model of bile reflux through ROS-mediated activation of PI3K/AKT and ERK1/2. In addition, CREB-specific siRNA and dominant-negative AP-1 (TAM67) blocked deoxycholate- and chenodeoxycholate – induced COX-2 induction. In the present study, we investigated the molecular mechanisms underlying DCA stimulated COX-2 signaling pathway in esophageal adenocarcinoma cells and their possible contribution to deregulated cell survival and apoptosis.
Methods
Chemicals
Phorbol 12-myristrate 13-acetate (PMA), acetylsalicidic acid, sodium deoxycholate (DCA) and ursodeoxycholate (UDCA) were from Sigma Chemical Co. (St. Louis, MO). PD 98059 (2'-amino-3'-methoxyflavone), SB 203580 (4-[4'-fluorophenyl]-2 [4'-methylsulfinylphenyl]-5-[4'-pyridyl] imidazole), Z-VAD-FMK (Z-Val-Ala-Asp-CH2F), Z-DEVD-FMK (Z-Asp(OCH3)-Glu(OCH3)-Val-Asp(OCH3)-FMK), U0126 (1,4-diamino-2,3-dicyano-1,4-bis [2-aminophenylthio] butadiene), phorbol 12,13-dibutyrate (PdBu) and anisomycin were from Calbiochem (LA Jolla, CA). Poly(dI-dC) and T4 polynucleotide kinase were from Amersham Biosciences (Buckinghamshire, UK).
Cell culture
The SKGT4 cell line, derived from a well-differentiated adenocarcinoma arising in Barrett's epithelium of the distal esophagus [
34] was generously provided by Dr. David Schrump (Bethesda, MA). The gastric adenocarcinoma cell line AGS was from ECACC (Salisbury, UK). Both cell lines were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 4 mM L-Glutamine, 50 units/ml penicillin and 50 μg/ml streptomycin (GIBCO BRL, Life Technologies, Paisley, Scotland) at 37°C in a humidified atmosphere containing 5% CO
2.
Electrophoretic mobility shift assay (EMSA)
Control and treated cells were harvested in ice cold phosphate buffered saline (PBS) and nuclear extracts were prepared as described previously [
35]. EMSA was performed on nuclear extracts with a double stranded 19-mer oligonucleotides containing the AP-1 binding motif, TGACTCA (12-O-tetradecanoylphorbol-13-acetate response element) as previously described [
36]. For supershift analysis, 450 ng of rabbit polyclonal antibodies against c-Jun, Fra-1, and c-Fos or unlabelled oligonucleotides, as a control, were mixed with 4 μg of nuclear extract 30 minutes prior to the binding reaction. Samples were subjected to 4% native polyacrylamide gels. Gels were dried and resulting AP-1 DNA binding complexes visualised by autoradiography.
Affinity precipitation with biotinylated oligonucleotides
Affinity precipitation of DNA binding proteins was performed with the optimal binding sequence for AP-1 (5'-CGC TTG ATG AGT CAG CCG GAA-3') (Sigma genosys UK) as previously described [
37] with the following modifications: total protein content was standardized to 300 – 400
μg/sample using a protein assay (Bio-Rad), according to the manufacturer's instructions. Equal protein content during affinity precipitation was assessed on acetone-precipitated supernatants.
Total cell lysates
SKGT4 cells were stimulated and total cell lysates obtained using 25 mM Tris-HCl, pH 7.9, 0.2% NP-40, 15 mM NaCl, 1 mM sodium fluoride, 5% glycerol (v/v), 0.05 mM EDTA, 1 mM Na3VO4 and 1 mM PMSF and 10 μg leupeptin (Sigma) and incubating on ice for 20 minutes. Cell nuclei and debris were eliminated by centrifugation at 10,000 × g for 10 min. The total protein content per sample was standardized to 50–100 μg as above.
Western blot analysis
Equal amounts of proteins were separated on a 10% SDS-polyacrylamide gel and transferred onto a PVDF membrane (Millipore Corp., Bedford, MA). Membranes were incubated with specific antibodies against Erk1/2, p38 and JNK (at a dilution of 1:1000) (Santa Cruz, CA) or their corresponding phosphorylated forms Erk1/2 (p-Tyr204-Erk1/2), JNK (p-Thr-183/Tyr-185-JNK) (Santa Cruz, CA) and p38 (p-Thr180/Tyr182-p38) (at a dilution of 1:50) (New England Biolabs, Hertfordshire, UK) overnight at 4°C. Antibodies against COX-2 (Cayman chemicals, Alexis Corp, UK) and PARP (Biosource International UK) (at a dilution of 1:100) were also used and incubated overnight at 4°C. Membranes were then incubated with corresponding secondary horseradish peroxidase-conjugated antibodies (Dako, Bucks, UK) (at a dilution of 1:2000) for 1 h at room temperature. Specific immunocomplexes were visualised using the ECL detection system (Amersham Biosciences, Buckinghamshire, UK). For sequential detection, membranes were stripped in 100 mM 2-Mercaptoethanol, 2% SDS, and 62.5 mM Tris pH 6.8 for 30–45 min at 50°C.
Cell Proliferation assay
SKGT4 cells (2.5 × 104) were plated in a flat-bottomed micro-titre plate and incubated for 24 hr at 37°C and 5% CO2. Cells were incubated either with increasing concentrations of DCA (0 – 500 μM) or over a period of 1 – 24 hr with 300 μM DCA. Following stimulation, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) (Promega Inc., Madison, WI.) was added and cells were further incubated for 1 to 3 hr. Absorbance was measured at 490 nm. Viability is expressed as the percentage of cells remaining in cultures treated with bile acids relative to untreated controls.
DNA fragmentation ELISA
DCA-induced toxicity was quantified using the cell death detection kit (Roche diagnostics, Penzberg, Germany) according to the manufacturer's standard protocols. Absorbance was measured at 405 nm using an ELISA plate reader.
Discussion
Bile acids are major constituents of the gastroesophageal refluxate and are regarded to have an important role in malignant development in the esophagus. [
15,
17]. A significant proportion of the bile acids in patients with extensive mucosal injury was composed of the dehydroxylated taurodeoxycholic acid and the unconjugated cholic and deoxycholic acids. Increased concentrations of bile acids (> 200 μM) have been observed in esophageal aspirates in patients with erosive esophagitis and Barrett's esophagus. [
15,
16,
18]. The exact molecular mechanism by which bile acids contribute to this process has not been defined. Alterations in gene expression underlie the ability of deoxycholate to deregulate biochemical processes and control the fate of the cells. The use of
in vitro cell culture model as in our study may be at variance with how cancer behaves in humans. However, the analysis of genes and molecules that are important in cancer development in cancer cell lines is of importance to our understanding of our interpretation of the
in vivo situation.
The purpose of this study was to investigate the mechanisms by which deoxycholate stimulates COX-2 and AP-1 expression and the role of COX-2 in the mediation of pro-apoptotic and anti-apoptotic mechanisms. Using electrophoretic mobility shift assays, we demonstrated that DCA induced persistent AP-1 DNA binding activity. AP-1 activation results from dimerisation of either pre-existing or newly synthesised phosphorylated proteins of the Fos and Jun families. Fra-1 and JunB are the predominant components of the sustained AP-1 complex, while c-Jun is only transiently induced. Interestingly, this AP-1 dimer composition is distinct from that induced by DCA in colonic epithelial cells where the induced complex contains JunD, Fra-1 and c-Fos [
47]. DCA-induced activation of Fra-1 was dependent on both the Mek1/2-Erk1/2 and p38 pathways, while JunB activation was mediated solely through the Mek1/2-Erk1/2 cascade in esophageal cells. It has previously been demonstrated that levels of Erk1/2 activity are greater in Barrett's esophagus than in GERD [
48]. In addition, duration of Erk1/2 activation determines composition and transcriptional output of AP-1 [
49]. Our data are in agreement with previous reports showing that sustained activation of Erk1/2 results in Fra-1 and JunB activation with negligible induction of c-Jun [
39].
The precise mechanisms utilized by duodenal reflux to elicit esophageal damage and promote tumorigenesis are uncertain. Accumulating evidence suggests that COX-2 is involved in the development of Barrett's esophagus and esophageal adenocarcinoma. COX-2 is frequently overexpressed in esophageal adenocarcinoma cells and tissues. [
19,
30,
31]. Song
et al. [
33] reported that the unconjugated bile acids chenodoxycholate and deoxycholate potently upregulate ROS production in the esophagus, leading to activation of the PI3K and ERK1/2 signaling pathways, with a subsequent CREB- and AP-1-dependent COX-2 expression. Here, we demonstrate a significant role for COX-2 in mediating survival in these cells, which is dose and time dependent. Exposure to DCA results in inhibition of proliferation with concomitant induction of low levels of apoptosis. Furthermore, DCA induces a dose- and time-dependent increase in COX-2 expression that parallels with PARP cleavage and DNA fragmentation. DCA-induced apoptosis is both dose- and time-dependent and requires caspase-3 activation. Furthermore the activation of Erk1/2 and p38 is crucial for DCA-induced COX-2 expression, an AP-1 target gene. Our findings strongly suggest that DCA induces pro- and anti-apoptotic signaling cascades and their combined activity determines cell fate.
Previous studies from our laboratory and others have demonstrated that DCA can induce NF-κB in esophageal cells [
50,
51]. DCA-induced PARP cleavage is dependent on caspase-3 activation [
52]. Therefore, simultaneous activation of caspase-3 and NF-κB explains the observed low levels of PARP cleavage induced by DCA. Glinghammar
et al. [
53] observed that in response to DCA, colonic cells undergo apoptosis and have low caspase-3 activation, strong activation of NF-κB and AP-1 transcription factors, and COX-2 expression. In agreement with these findings, we have demonstrated that SKGT4 cells exposure to DCA resulted in low levels of caspase-3-dependent PARP cleavage, activation of NF-κB and AP-1, and substantial induction COX-2 expression.
AP-1 dimer composition is critical in determining its functional activity and consequently in the induction of specific target genes [
20,
24,
25]. The Fos family members and c-Jun are positive regulators of cell proliferation and have been shown to mediate oncogenic transformation in fibroblasts [
54]. In the absence of c-Jun in mouse embryonic fibroblasts, JunB acts as a positive growth regulator [
20]. However, when both molecules are expressed, JunB prevents c-Jun DNA binding, transactivation and consequent transformation potential [
55,
56]. Hence as both molecules are constitutively expressed in SKGT4 cells, the enhanced levels of JunB induced by DCA might potentially have a negative effect on c-Jun DNA binding. Fos and Jun proteins can heterodimerise while only the members of the Jun family are capable of homodimerisation. Fos/Jun heterodimers are more stable than Jun homodimers [
23]. Therefore, our data suggest that a Fra-1/JunB heterodimer is the DCA-induced AP-1 complex. In these circumstances, this complex could act as a growth promoter in response to DCA in esophageal cells.
Bile acids can exert their tumor promoting activity by affecting intracellular signaling pathways, which alters proliferation and apoptosis. MAPKs constitute an important group of signaling mediators that govern cellular processes such as proliferation and cell death. DCA promotes cell survival through the induction of MAPKs in primary hepatocytes and colonic cells [
11,
28]. The present study demonstrated that DCA activated the MAPKs Erk1/2 and p38, but it is unable to regulate JNK activation. COX-2 expression can also be regulated by MAPKs both directly by mRNA stabilization as shown in intestinal epithelial cells and monocytes [
29,
32,
57] and indirectly through activation of AP-1 complexes [
33]. Here we used specific pharmacological inhibitors of the MAPK cascades to identify the pathways mediating DCA-induced COX-2 expression in SKGT4 cells. COX-2 expression was completely blocked by the PD98059 and SB203580 compounds demonstrating the involvement of Raf-Mek1/2-Erk1/2 and MMK3/6-p38 pathways in DCA-induced COX-2 expression. COX-2 may be specifically important in esophageal carcinogenesis, as COX-2 expression is frequently upregulated in Barrett's esophagus, esophageal cancer and in animal models of reflux [
19,
30,
31]. The specificity of pharmacological inhibitors should be considered, because many of these inhibitors block various signal transduction proteins. However, MAPKs inhibitors such as PD98059 and SB203580 are well-established specific inhibitors of ERK and p38 pathway, respectively, and have been tested in many systems for their specificity in inhibiting MAPKs activity.
In vitro, prolonged exposure of colonic cells to DCA induced apoptosis and caused morphological changes that were characteristic of apoptosis [
10], however, apoptosis resistant clones may be selected after frequent exposure to the cytotoxic bile DCA [
58].
In vivo, bile acid-induced apoptosis has been linked with compensatory proliferation of crypt epithelial cells [
59]. Rates of apoptosis have been demonstrated to be low in Barrett's epithelium [
60], potentially contributing to the malignant process. While DCA induced low levels of apoptosis in this study, the effects on cell survival appear to have been balanced at least partially through DCA-induced COX-2. Specifically DCA-induced PARP cleavage was enhanced by COX inhibition. However, other MAPK-regulated pathways such as induction of the anti-apoptotic proteins Mcl-1 and cFLIP and Bcl-2 might also contribute to esophageal cell survival in response to DCA [
61].
Reflux of duodenal contents appears to contribute to the development of esophagitis and Barrett's adenocarcinoma [
15,
17] DCA-induced sustained AP-1 activation is likely to have important implications in esophageal tumorigenesis considering that blockage of DMBA (7,12-dimethylbenz [
a]anthracene)/PMA-induced AP-1 activity in transgenic mice has been demonstrated to prevent neoplastic transformation in a murine keratinocyte model [
22]. DCA stimulation also results in sustained expression of the anti-apoptotic protein COX-2. Long-term intermittent exposure of esophageal tissue to DCA such as that caused by duodenal reflux will therefore likely lead to sustained MAPK and AP-1 activation, as well as over-expression of COX-2. Persistent activation of MAPK can lead to enhanced cell proliferation possibly via cyclin D1 expression [
62]. It is well known that MAPKs regulate the downstream phosphorylation of nuclear transcription factors such as AP-1 and NF-κB, which regulate several cellular events including apoptosis and proliferation. Cytokines that are stimulated by NF-κB, such as IL-1β and TNF-α, released in response to chronic gastroesophageal reflux, can also directly activate the AP-1 and NF-κB pathway.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
EL carried out the study and prepared the manuscript. MAL participated in the design of the study experimentation and edited the manuscript. VAM made contributions to the study methodology of MAPK and AP-1 analysis. SD contributed to the design of the study experimentation and drafting of the manuscript. AL coordinated the study and edited the manuscript. DK designed and supervised the study. All authors have read and approved the final manuscript.